Drugs / Aurixim
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03057418 | Jun 2013 → Dec 2016 | follicular lymphoma | Biointegrator LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aurixim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03057418 ↗ |
| Route | Intravenous | “Mode of administration: intravenous.” NCT03057418 ↗ |